Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Organophosphate Test System
fda-device · Food and Drug Administration · Rule · Published 2017-10-18 · Effective 2017-10-18 · 82 FR 48413
Document
Document number
2017-22590
Federal Register citation
82 FR 48413
CFR reference
21 CFR 862
Type
Rule
Action
Final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2017-10-18
Effective date
2017-10-18
HHS docket
Docket No. FDA-2017-N-5160
Abstract
The Food and Drug Administration (FDA or we) is classifying the organophosphate test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the organophosphate test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.